Literature DB >> 33788669

Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm?

Lisa Dannenberg1, René M'Pembele2, Philipp Mourikis1, Carolin Helten1, Saif Zako1, Samantha Ahlbrecht1, Hannah Richter1, Dorothee Zikeli1, Marcel Benkhoff1, Ragnar Huhn-Wientgen2, Manuela Thienel3, Bodo Levkau4, Malte Kelm1, Tobias Petzold3, Amin Polzin1.   

Abstract

Entities:  

Keywords:  Aggregation; aspirin; major adverse cardiovascular and cerebrovascular events; platelet inhibition; rivaroxaban; thromboxane

Mesh：

Substances：

Year:  2021        PMID： 33788669     DOI： 10.1080/09537104.2021.1905159

Source DB:  PubMed          Journal:  Platelets        ISSN： 0953-7104            Impact factor:   3.862


× No keyword cloud information.
  1 in total

1.  Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro.

Authors:  Herm Jan M Brinkman; Frauke Swieringa; Marleen Zuurveld; Alicia Veninga; Sanne L N Brouns; Johan W M Heemskerk; Joost C M Meijers
Journal:  Res Pract Thromb Haemost       Date:  2022-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.